[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2022-2026 North America Hematology and Flow Cytometry Analyzer and Reagent Markets-Growth Opportunities in the US, Canada and Mexico, Supplier Shares, Test Volume and Sales Segment Forecasts—Competitive Strategies, Instrumentation Pipeline, Latest Technologies

December 2021 | | ID: 254D17058D14EN
Venture Planning Group

US$ 9,700.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source.

This new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test, and can be customized to specific information needs and budget.

The survey is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities emerging in the hematology and flow cytometry markets during the next five years.

Rationale

Continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets. New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, auto-calibration and other advanced features. Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.

Country Analyses

Canada, Mexico, USA

Strategic Recommendations
  • New product development opportunities with significant market appeal.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
Market Segmentation Analysis
  • Sales and market share estimates of leading hematology and flow cytometry product suppliers in major countries.
  • Specimen, test and sales forecasts for over 40 procedures.
Sales and Market Share Analysis

Sales and market shares of major instrument and reagent suppliers in major countries.

Hematology Tests Analyzed in the Report

CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils

Flow Cytometry Tests Analyzed in the Report

Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing

Instrumentation Review

Reviews of current instrumentation technologies, and features of leading hematology, flow cytometry, platelet aggregation and sedimentation rate analyzers.

The report features analyzers marketed by Abbott, Beckman Coulter/Danaher, Becton Dickinson, Biocode Hycel, CellaVision, Diesse Ves Matic, Drew-Scientific, Horiba, Medica, Menarini, Nihon Kohden, Polymedco, Siemens, Sysmex and other suppliers.

Technology Review
  • Assessment of current and emerging technologies and their potential market applications.
  • Companies developing or marketing new technologies and products by test.
Competitive Assessments

Strategic profiles of major suppliers and emerging market entrants.
I. INTRODUCTION

II. MARKET OVERVIEW

III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products

IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

V. ALTERNATIVE MARKET PENETRATION STRATEGIES

VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

VII. MARKET AND TECHNOLOGY OVERVIEW

A. Major Routine and Special Hematology Tests
  1. Introduction
  2. CBC Analysis
    a. Hemoglobin Concentration
    b. Hematocrit Determination
    c. Red Blood Cell Count
    d. Red Cell Indices
  MCV
  RDW
  MCHC
  CHCM
  HDW
  MCH
    e. Red Cell Size Histograms
    f. Platelets
  Platelet Count
  Platelet Size/MPV
  PDW
  Automated Systems
    g. Reticulocytes
  3. White Blood Cell Analysis
    a. WBC Count
    b. Five-Partial Differential Major Suppliers
    c. Pattern Recognition Systems
    d. Comparison of Major Differential Analyzers
  4. Reticulocytes
  5. Platelet Function Tests
  6. Erythrocyte Sedimentation Rate/CRP
  7. Red Cell Analysis
  8. 2, 3 DPG
  9. Red Cell Deformability
  10. Neutrophil Function Tests
  11. Semen Analysis
  12. Bone Marrow Analysis
  13. Urinalysis
B. Major Flow Cytometry Applications
  1. Cell Surface Markers
    a. Lymphocyte Subclassification CD4/CD8/CD34
  Instrumentation and Reagent Test Kits
    b. Other Cell Markers
  2. DNA Content Analysis
  3. RNA Content Analysis
  4. Chemotherapy Monitoring
  5. Cell Cycle Analysis
  6. Chromosome Analysis
  7. Fetal Cell Analysis
  8. HLA Typing
  9. Microbiology
  10. Protein Content Analysis
  11. Multiparameter Analysis
  12. Other Applications
C. Hematology and Flow Cytometry Instrumentation Review
  1. Hematology Analyzers
    a. Overview
  Electrical Aperture-Impedance Analyzers
  Light Scatter Analyzers
    b. System Review
  Abbott
  Beckman Coulter/Danaher
  Biocode Hycel
  CellaVision
  Drew-Scientific
  Horiba
  Medica
  Menarini
  Nihon Kohden
  Siemens
  Sysmex
  2. Flow Cytometers
    a. Introduction
    b. System Overview
  3. Platelet Aggregometers
  4. Sedimentation Rate Analyzers
D. Market Needs and Future Demand for Hematology and Flow Cytometry Analyzers
E. Reagents and Controls
F. Current and Emerging Technologies
  1. Information Technologies
  2. Automation and Robotics
  3. Lasers
  4. Artificial Intelligence
  5. Monoclonal Antibodies
  6. Molecular Diagnostics
  7. Microdrop Technology

VIII. COUNTRY ANALYSES: SUPPLIER SHARES, SPECIMEN, VOLUME AND SALES FORECASTS FOR 40 TESTS

Canada
Mexico
USA

IX. COMPETITIVE ASSESSMENTS

The report provides strategic assessments of over 15 leading hematology and flow cytometry market players and start-up companies with innovative technologies and products, including:
  Abbott
  Agilent Technologies
  Beckman Coulter/Danaher
  Becton Dickinson
  Bio-Rad
  CellaVision
  Horiba
  Nihon Kohden
  Ortho-Clinical Diagnostics
  Roche
  Sekisui Diagnostics
  Siemens Healthineers
  Sysmex and others

LIST OF TABLES

Canada All Market Segments Total Hematology and Flow Cytometry Specimen Volume Forecast
Canada All Market Segments Total Hematology and Flow Cytometry Test Volume Forecast
Canada All Market Segments Total Hematology and Flow Cytometry Market Forecast
Canada All Market Segments, Total Routine Hematology Test Volume Forecast by Assay
Canada All Market Segments, Total Flow Cytometry and Special Hematology Test Volume Forecast by Assay
Mexico All Market Segments Total Hematology and Flow Cytometry Specimen Volume Forecast
Mexico All Market Segments Total Hematology and Flow Cytometry Test Volume Forecast
Mexico All Market Segments Total Hematology and Flow Cytometry Market Forecast
Mexico All Market Segments, Total Routine Hematology Test Volume Forecast by Assay
Mexico All Market Segments, Total Flow Cytometry and Special Hematology Test Volume Forecast by Assay
U.S., Laboratories Performing Hematology/Flow Cytometry Testing by Market Segment
U.S., Hospital Laboratories Performing Hematology and Flow Cytometry Tests By Bed Size
U.S., Commercial/Private Laboratories Performing Hematology/Flow Cytometry Tests by Annual Test Volume
U.S., Physician Offices/Group Practices Performing Hematology/Flow Cytometry Tests by Annual Test Volume
U.S., Total Routine Hematology Specimen Volume Forecast By Market Segment
U.S., Total Flow Cytometry and Special Hematology Specimen Volume Forecast By Market Segment
U.S., Hospital Laboratories, Hematology and Flow Cytometry Specimen Volume Forecast
U.S., Physician Offices/Group Practices, Hematology and Flow Cytometry Specimen Volume Forecast
U.S., Commercial/Private Laboratories, Hematology and Flow Cytometry Specimen Volume Forecast
U.S., Total Routine Hematology Test Volume Forecast by Market Segment
U.S., Total Flow Cytometry and Special Hematology Test Volume Forecast By Market Segment
U.S., All Market Segments, Total Routine Hematology Test Volume Forecast
U.S., Hospital Laboratories, Routine Hematology Test Volume Forecast
U.S., Commercial/Private Laboratories, Routine Hematology Test Volume Forecast
U.S., Physician Office Laboratories, Routine Hematology Test Volume Forecast
U.S., All Market Segments, Flow Cytometry and Special Hematology Test Volume Forecast
U.S., Hospital Laboratories, Flow Cytometry and Special Hematology Test Volume Forecast
U.S., Commercial/Private Laboratories, Flow Cytometry and Special Hematology Test Volume Forecast
U.S., Physician Office Laboratories, Flow Cytometry and Special Hematology Test Volume Forecast
U.S., Total Hematology Market by Market Segment Forecast
U.S., Total Flow Cytometry Market Forecast by Market Segment
U.S., Total Hematology Market by Major Supplier
U.S., Total Flow Cytometry Market by Major Supplier


More Publications